Home Newsfeeds Barclays Maintains Underweight on ManpowerGroup, Lowers Price Target to $80

Barclays Maintains Underweight on ManpowerGroup, Lowers Price Target to $80

Barclays analyst Manav Patnaik maintains ManpowerGroup (NYSE:MAN) with a Underweight and lowers the price target from $100 to $80.

byBenzinga Newsdesk

July 22, 2022

1 minute read

Barclays analyst Manav Patnaik maintains ManpowerGroup (NYSE:MAN) with a Underweight and lowers the price target from $100 to $80.

Analyst Ratings

Evaluating Pacific Premier Bancorp: Insights From 4 Financial Analysts

By Benzinga Insights

January 30, 8:00 AM

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Pacific Premier…

PPBI

SCYNEXIS To Present Preclinical Data On Second Generation Fungerp SCY-247 At The 11th Congress On Trends In Medical Mycology October 20-23 In Athens, Greece

By Benzinga Newsdesk

October 16, 8:27 AM

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical data on its

SCYX

Why This Moderna Analyst Is Very Bullish

By Priya Nigam

March 2, 12:54 PM

Shares of Moderna Inc (NASDAQ: MRNA) have lost almost 24% year to date. While the prospects of the Covid-vaccine seem to be waning, data from the cancer vaccine is impressive, according to RBC Capital Markets.

MRNA